[13] recently reported that GLP-1 RAs are not associated with an increased risk of intestinal obstruction in patients with inflammatory bowel disease using Danish health registries
As with any medication, there are potential side effects, including nausea, vomiting, diarrhea, and constipation, and it may not be suitable for everyone
Quick Answer: GLP-1 medications typically cause modest blood pressure reductions of 2-6 mmHg, but some patients may experience symptomatic low blood pressure, particularly when combined with antihypertensive medications, significant weight loss, or dehydration from gastrointestinal side effects
The FDA warns that these products are of unknown quality and may be harmful
Contact your provider
Microdosing GLP-1 for Hashimoto's: Evidence, Risks and NHS Guidance Microdosing GLP-1 for Hashimoto's has emerged as a topic of interest amongst patients seeking metabolic support for autoimmune thyroid disease